RETRACTED ARTICLE: Immobilization of carborane derivatives on Ni/Fe nanotubes for BNCT
This record is marked as retracted by the source. Review the publisher’s notice before using its findings.
Source abstract
Abstract
The most important limitation for boron neutron capture therapy of cancer is the selective accumulation of boron compounds in tumor tissues in significant quantities. In this paper, we describe the possibility to use magnetic Ni/Fe nanotubes as carriers for boron delivery. Carborane derivatives containing 10 and 21 boron atoms per molecule were immobilized on Ni/Fe nanotubes by covalent and ionic interactions. Magnetic properties of NTs were investigated by Mössbauer spectroscopy. Structure, element, chemical composition, and morphology of obtained magnetic nanotubes were studied by XRD, SEM-EDA, and FTIR spectroscopy. Results indicate success immobilization of carborane derivatives on Ni/Fe nanotubes and great potential to use them as carriers for boron neutron cancer therapy of cancer. ᅟ
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Boron Compounds in Chemistry · Boron and Carbon Nanomaterials Research · Radiopharmaceutical Chemistry and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Aihara T, Morita N, Kamitani N, Kumada H, Ono K, Hiratsuka J, Harada T (2014) BNCT for advanced or recurrent head and neck cancer. Appl Radiat Isot 88:12–15. https://doi.org/10.1016/j.apradiso.2014.04.00710.1016/j.apradiso.2014.04.007 ↗
2. Akan Z (2015) Boron neutron capture therapy for breast Cancer. Int J Women’s Heal Reprod Sci 3:77. https://doi.org/10.15296/ijwhr.2015.1410.15296/ijwhr.2015.14 ↗
3. Akbarzadeh A, Samiei M, Davaran S (2012) Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett 7:144. https://doi.org/10.1186/1556-276X-7-14410.1186/1556-276X-7-144 ↗
4. Altieri S, Balzi M, Bortolussi S, Bruschi P, Ciani L, Clerici AM, Faraoni P, Ferrari C, Gadan MA, Panza L, Pietrangeli D, Ricciardi G, Ristori S (2009) Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy. J Med Chem 52:7829–7835. https://doi.org/10.1021/jm900763b10.1021/jm900763b ↗
5. Arami H, Khandhar A, Liggitt D, Krishnan KM (2015) In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev 44:8576–8607. https://doi.org/10.1039/C5CS00541H10.1039/C5CS00541H ↗
6. Azhar SLB, Lotfipour F (2012) Magnetic nanoparticles for antimicrobial drug delivery. Pharmazie 67:817–821
7. Baskaran M, Baskaran P, Arulsamy N, Thyagarajan B (2017) Preparation and evaluation of PLGA-coated capsaicin magnetic nanoparticles. Pharm Res 34:1255–1263. https://doi.org/10.1007/s11095-017-2142-210.1007/s11095-017-2142-2 ↗
8. Chakrabarti A, Hosmane NS (2012) Nanotechnology-driven chemistry of boron materials. Pure Appl Chem 84:2299–2308. https://doi.org/10.1351/PAC-CON-12-01-0510.1351/PAC-CON-12-01-05 ↗
9. Cioran AM, Teixidor F, Krpetić Ž et al (2014) Preparation and characterization of Au nanoparticles capped with mercaptocarboranyl clusters. Dalton Trans 43:5054–5061. https://doi.org/10.1039/c3dt52872c10.1039/c3dt52872c ↗
10. Fang C, Wang K, Stephen ZR, Mu Q, Kievit FM, Chiu DT, Press OW, Zhang M (2015) Temozolomide nanoparticles for targeted glioblastoma therapy. ACS Appl Mater Interfaces 7:6674–6682. https://doi.org/10.1021/am509216510.1021/am5092165 ↗
11. Giustini AJ, Petryk AA, Cassim SM et al (2010) Magnetic nanoparticle hyperthermia in cancer treatment. Nano Life 01:17–32. https://doi.org/10.1142/S179398441000006710.1142/S1793984410000067 ↗
12. Henriksson R, Capala J, Michanek A, Lindahl SA, Salford LG, Franzén L, Blomquist E, Westlin JE, Bergenheim AT, Swedish Brain Tumour Study Group (2008) Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). Radiother Oncol 88:183–191. https://doi.org/10.1016/j.radonc.2006.04.01510.1016/j.radonc.2006.04.015 ↗
13. Heying TL, Ager JW, Clark SL et al (1963) A new series of organoboranes. III. Some reactions of 1,2-dicarbaclovododecaborane(12) and its derivatives. Inorg Chem 2:1097–1105. https://doi.org/10.1021/ic50010a00410.1021/ic50010a004 ↗
14. Hosseini F, Seyedsadjadi M, Farhadyar N (2014) Fe3O4 nanoparticles modified with APTES as the carrier for (+)-(S)-2-(6-methoxynaphthalen-2-yl) propanoic acid (naproxen) and (RS) 2-(3-benzoylphenyl)-propionic acid (Ketoprofen) drug. Orient J Chem 30:1609–1618. https://doi.org/10.13005/ojc/30042010.13005/ojc/300420 ↗
15. Kozlovskiy AL, Korolkov IV, Kalkabay G et al (2017) Comprehensive study of Ni nanotubes for bioapplications: from synthesis to payloads attaching. J Nanomater. https://doi.org/10.1155/2017/306097210.1155/2017/3060972 ↗
16. Liebelt EL, Shannon MW (1993) Small doses, big problems: a selected review of highly toxic common medications. Pediatr Emerg Care 9:292–29710.1097/00006565-199310000-00008 ↗
17. Liu Y, Li Y, Li X-M, He T (2013) Kinetics of (3-Aminopropyl)triethoxylsilane (APTES) silanization of superparamagnetic iron oxide nanoparticles. Langmuir 29:15275–15282. https://doi.org/10.1021/la403269u10.1021/la403269u ↗
18. Matsnev ME, Rusakov VS (2012) SpectrRelax: an application for Mössbauer spectra modeling and fitting. AIP Conf Proc 1489:178–185. https://doi.org/10.1063/1.475948810.1063/1.4759488 ↗
19. McBain SC, Yiu HHP, Dobson J (2008) Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine 3:169–180
20. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66:271–289. https://doi.org/10.3322/caac.2134910.3322/caac.21349 ↗
21. Miyajima Y, Nakamura H, Kuwata Y, et al (2006) Transferrin-loaded nido-carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy. Bioconjug Chem 17:1314–1320. https://doi.org/10.1021/BC060064K10.1021/bc060064k ↗
22. Nafiujjaman M, Revuri V, Nurunnabi M, Jae Cho K, Lee YK (2015) Photosensitizer conjugated iron oxide nanoparticles for simultaneous in vitro magneto-fluorescent imaging guided photodynamic therapy. Chem Commun 51:5687–5690. https://doi.org/10.1039/C4CC10444G10.1039/C4CC10444G ↗
23. Nakai K, Matsumura A (2012) Feasibility for intramedullary spinal glioma. In: Neutron capture therapy. Springer Berlin Heidelberg, Berlin, pp 407–41510.1007/978-3-642-31334-9_23 ↗
24. Nedunchezhian K, Aswath N, Thiruppathy M, Thirugnanamurthy S (2016) Boron neutron capture therapy - a literature review. J Clin Diagn Res 10:ZE01–ZE04. https://doi.org/10.7860/JCDR/2016/19890.902410.7860/JCDR/2016/19890.9024 ↗
25. Niemirowicz K, Durnaś B, Tokajuk G, Głuszek K, Wilczewska AZ, Misztalewska I, Mystkowska J, Michalak G, Sodo A, Wątek M, Kiziewicz B, Góźdź S, Głuszek S, Bucki R (2016) Magnetic nanoparticles as a drug delivery system that enhance fungicidal activity of polyene antibiotics. Nanomedicine 12:2395–2404. https://doi.org/10.1016/j.nano.2016.07.00610.1016/j.nano.2016.07.006 ↗
26. Pak RH, Primus FJ, Rickard-Dickson KJ, Ng LL, Kane RR, Hawthorne MF (1995) Preparation and properties of nido-carborane-specific monoclonal antibodies for potential use in boron neutron capture therapy for cancer. Proc Natl Acad Sci U S A 92:6986–699010.1073/pnas.92.15.6986 ↗
27. Pasternack RM, Amy SR, Chabal YJ (2008) Attachment of 3-(Aminopropyl) triethoxysilane on silicon oxide surfaces: dependence on solution temperature. Langmuir 7:12963–12971. https://doi.org/10.1021/la802482710.1021/la8024827 ↗
28. Revia RA, Zhang M (2016) Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances. Mater Today 19:157–168. https://doi.org/10.1016/j.mattod.2015.08.02210.1016/j.mattod.2015.08.022 ↗
29. Ruggiero MR, Geninatti Crich S, Sieni E, Sgarbossa P, Cavallari E, Stefania R, Dughiero F, Aime S (2017) Iron oxide/PLGA nanoparticles for magnetically controlled drug release. Int J Appl Electromagn Mech 53:S53–S60. https://doi.org/10.3233/JAE-16224610.3233/JAE-162246 ↗
30. Sauerwein WAG (2012) Principles and roots of neutron capture therapy. In: Neutron capture therapy. Springer Berlin Heidelberg, Berlin, Heidelberg, pp 1–16. https://doi.org/10.1007/978-3-642-31334-9_110.1007/978-3-642-31334-9 ↗
31. Shumskaya AE, Kaniukov EY, Kozlovskiy AL et al (2017) Template synthesis and magnetic characterization of FeNi nanotubes. Prog Electromagn Res C 75:23–3010.2528/PIERC17030606 ↗
32. Singh R, Lillard JW Jr (2009) Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86:215–223. https://doi.org/10.1016/j.yexmp.2008.12.00410.1016/j.yexmp.2008.12.004 ↗
33. Strehl C, Gaber T, Maurizi L, Hahne M, Rauch R, Hoff P, Hofmann-Amtenbrink M, Poole R, Hofmann H, Buttgereit F, Häupl T (2015) Effects of PVA coated nanoparticles on human immune cells. Int J Nanomedicine 10:3429. https://doi.org/10.2147/IJN.S7593610.2147/IJN.S75936 ↗
34. Sumitani S, Nagasaki Y (2012) Boron neutron capture therapy assisted by boron-conjugated nanoparticles. Polym J 44:522–530. https://doi.org/10.1038/pj.2012.3010.1038/pj.2012.30 ↗
35. Sumitani S, Oishi M, Nagasaki Y (2011) Carborane confined nanoparticles for boron neutron capture therapy: improved stability, blood circulation time and tumor accumulation. React Funct Polym 71:684–693. https://doi.org/10.1016/j.reactfunctpolym.2011.03.01010.1016/j.reactfunctpolym.2011.03.010 ↗
36. Tamyurek E, Maltas E, Bas SZ, Ozmen M, Yildiz S (2015) Magnetic nanoparticles–serum proteins bioconjugates for binding of irinotecan. Int J Biol Macromol 73:76–83. https://doi.org/10.1016/j.ijbiomac.2014.10.06110.1016/j.ijbiomac.2014.10.061 ↗
37. Tietze R, Unterweger H, Dürr S, Lyer S, Canella L, Kudejova P, Wagner FM, Petry W, Taccardi N, Alexiou C (2015) Boron containing magnetic nanoparticles for neutron capture therapy - an innovative approach for specifically targeting tumors. Appl Radiat Isot 106:151–155. https://doi.org/10.1016/j.apradiso.2015.07.02810.1016/j.apradiso.2015.07.028 ↗
38. Uchida E, Uyama Y, Ikada Y (1993) Sorption of low-molecular-weight anions into thin polycation layers grafted onto a film. Langmuir 9:1121–1124. https://doi.org/10.1021/la00028a04010.1021/la00028a040 ↗
39. Weissleder R, Stark D, Engelstad B, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. Am J Roentgenol 152:167–173. https://doi.org/10.2214/ajr.152.1.16710.2214/ajr.152.1.167 ↗
40. Xu J, Sun J, Wang Y, Sheng J, Wang F, Sun M (2014) Application of Iron magnetic nanoparticles in protein immobilization. Molecules 19:11465–11486. https://doi.org/10.3390/molecules19081146510.3390/molecules190811465 ↗
41. Yanagie H, Kumada H, Sakurai Y, Nakamura T, Furuya Y, Sugiyama H, Ono K, Takamoto S, Eriguchi M, Takahashi H (2009) Dosimetric evaluation of neutron capture therapy for local advanced breast cancer. Appl Radiat Isot 67:S63–S66. https://doi.org/10.1016/j.apradiso.2009.03.11010.1016/j.apradiso.2009.03.110 ↗
42. Yinghuai Z, Peng AT, Carpenter K, et al (2005) Substituted carborane-appended water-soluble single-wall carbon nanotubes: new approach to boron neutron capture therapy drug delivery. J Am Chem Soc 127:9875–9880. https://doi.org/10.1021/JA051711610.1021/ja0517116 ↗
43. Yu S, Wu G, Gu X, Wang J, Wang Y, Gao H, Ma J (2013) Magnetic and pH-sensitive nanoparticles for antitumor drug delivery. Colloids Surfaces B Biointerfaces 103:15–22. https://doi.org/10.1016/j.colsurfb.2012.10.04110.1016/j.colsurfb.2012.10.041 ↗
44. Zakharkin LI, Ol’shevskaya VA, Spryshkova RA et al (2000) Synthesis of bis(dialkylaminomethyl)-o-andm-carboranes and study of these compounds as potential preparations for boron neutron capture therapy. Pharm Chem J 34:301–304. https://doi.org/10.1007/BF0252440810.1007/BF02524408 ↗
45. Zhang Y, Zhu L, Zhou Y, Chen J (2015) Accumulation and elimination of iron oxide nanomaterials in zebrafish (Danio rerio) upon chronic aqueous exposure. J Environ Sci 30:223–230. https://doi.org/10.1016/j.jes.2014.08.02410.1016/j.jes.2014.08.024 ↗
46. Zhu Y, Lin Y, Zhu YZ, Lu J, Maguire JA, Hosmane NS (2010) Boron drug delivery via encapsulated magnetic nanocomposites: a new approach for BNCT in cancer treatment. J Nanomater 2010:1–8. https://doi.org/10.1155/2010/40932010.1155/2010/409320 ↗